Impact of Providing a Combination Lipid Emulsion Compared with a Standard Soybean Oil Lipid Emulsion in Children Receiving Parenteral Nutrition

Journal of Parenteral and Enteral Nutrition

Volumn 39, Issue 6, 2015, Pages 656-667

  Finn, Kristen Lawler ^a   Chung, Mei ^b   Rothpletz Puglia, Pamela ^a   Byham Gray, Laura ^a  

^a Rutgers University   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; BILIRUBIN GLUCURONIDE; LIPID EMULSION; SOYBEAN OIL; TRIACYLGLYCEROL; ALPHA TOCOPHEROL; FATTY ACID; FISH OIL; OLIVE OIL; OMEGA 6 FATTY ACID;

ARTICLE; BILIRUBIN BLOOD LEVEL; CONFIDENCE INTERVAL; GOLD STANDARD; HUMAN; INCIDENCE; INFECTION; META ANALYSIS; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; ADVERSE EFFECTS; BLOOD; CHEMISTRY; CHILD; COMMUNICABLE DISEASES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

GLYCINE MAX;

ALPHA-TOCOPHEROL; BILIRUBIN; CHILD; COMMUNICABLE DISEASES; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS; FATTY ACIDS, OMEGA-6; FISH OILS; HUMANS; INCIDENCE; OLIVE OIL; PARENTERAL NUTRITION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOYBEAN OIL; TRIGLYCERIDES;

EID: 84937861841     PISSN: 01486071     EISSN: 19412444     Source Type: Journal    
DOI: 10.1177/0148607114542515     Document Type: Article

References (53)

1. Vanek VW, Seidner DL, Allen P,. A.S.P.E.N. position paper: clinical role for alternative intravenous fat emulsions. Nutr Clin Pract. 2012; 27 (2): 150-192.
2. de Meijer VE, Gura KM, Meisel JA, Le HD, Puder M,. Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease. Arch Surg. 2010; 145 (6): 547-551.
3. Diamond IR, Sterescu A, Pencharz PB, Kim JH, Wales PW,. Changing the paradigm: Omegaven for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastr Nutr. 2009; 48 (2): 209-215.
4. Wei C, Hua J, Bin C, Klassen K,. Impact of lipid emulsion containing fish oil on outcomes of surgical patients: systematic review of randomized controlled trials from Europe and Asia. Nutrition. 2010; 26 (5): 474-481.
5. Chen B, Zhou Y, Yang P, Wan HW, Wu XT,. Safety and efficacy of fish oil-enriched parenteral nutrition regimen on postoperative patients undergoing major abdominal surgery: a meta-analysis of randomized controlled trials. JPEN J Parenter Enteral Nutr. 2010; 34 (4): 387-394.
6. Seida JC, Mager DR, Hartling L, Vandermeer B, Turner JM,. Parenteral omega-3 fatty acid lipid emulsions for children with intestinal failure and other conditions: a systematic review. JPEN J Parenter Enteral Nutr. 2013; 37 (1): 44-55.
7. Rangel SJ, Calkins CM, Cowles RA,. Parenteral nutrition-associated cholestasis: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J Pediatr Surg. 2012; 47 (1): 225-240.
8. Waitzberg DL, Torrinhas RS, Jacintho TM,. New parenteral lipid emulsions for clinical use. JPEN J Parenter Enteral Nutr. 2006; 30 (4): 351-367.
9. Koletzko B, Goulet O, Hunt J, Krohn K, Shamir R,. 1. Guidelines on paediatric parenteral nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr. 2005; 41 (suppl 2): S1-S87.
10. Goulet O, Ruemmele F,. Causes and management of intestinal failure in children. Gastroenterology. 2006; 130 (2)(suppl 1): S16-S28.
11. Worthington PH, Gilbert KA,. Parenteral nutrition: risks, complications, and management. J Infus Nurs. 2012; 35 (1): 52-64.
12. Visschers RG, Olde Damink SW, Gehlen JM, Winkens B, Soeters PB, van Gemert WG,. Treatment of hypertriglyceridemia in patients receiving parenteral nutrition. JPEN J Parenter Enteral Nutr. 2011; 35 (5): 610-615.
13. Druml W, Fischer M, Pidlich J, Lenz K,. Fat elimination in chronic hepatic failure: long-chain vs medium-chain triglycerides. Am J Clin Nutr. 1995; 61 (4): 812-817.
14. Gura KM, Puder M,. Rapid infusion of fish oil-based emulsion in infants does not appear to be associated with fat overload syndrome. Nutr Clin Pract. 2010; 25 (4): 399-402.
15. Klein CJ, Revenis M, Kusenda C, Scavo L,. Parenteral nutrition-associated conjugated hyperbilirubinemia in hospitalized infants. J Am Diet Assoc. 2010; 110 (11): 1684-1695.
16. Sala-Vila A, Barbosa VM, Calder PC,. Olive oil in parenteral nutrition. Curr Opin Clin Nutr Metab Care. 2007; 10 (2): 165-174.
17. Teague H, Rockett BD, Harris M, Brown DA, Shaikh SR,. Dendritic cell activation, phagocytosis and CD69 expression on cognate T cells are suppressed by n-3 long-chain polyunsaturated fatty acids. Immunology. 2013; 139 (3): 386-394.
18. Deshpande G, Simmer K,. Lipids for parenteral nutrition in neonates. Curr Opin Clin Nutr Metab Care. 2011; 14 (2): 145-150.
19. Kalogeropoulos N, Panagiotakos DB, Pitsavos C,. Unsaturated fatty acids are inversely associated and n-6/n-3 ratios are positively related to inflammation and coagulation markers in plasma of apparently healthy adults. Clinica Chim Acta. 2010; 411 (7-8): 584-591.
20. Miloudi K, Comte B, Rouleau T, Montoudis A, Levy E, Lavoie J-C,. The mode of administration of total parenteral nutrition and nature of lipid content influence the generation of peroxides and aldehydes. Clin Nutr. 2012; 31 (4): 526-534.
21. Kurvinen A, Nissinen MJ, Andersson S,. Parenteral plant sterols and intestinal failure-associated liver disease in neonates. J Pediatr Gastr Nutr. 2012; 54 (6): 803-811.
22. Duerksen DR, Van Aerde JE, Chan G, Thomson AB, Jewell LJ, Clandinin MT,. Total parenteral nutrition impairs bile flow and alters bile composition in newborn piglet. Digest Dis Sci. 1996; 41 (9): 1864-1870.
23. Trauner M, Meier PJ, Boyer JL,. Molecular pathogenesis of cholestasis. N Engl J Med. 1998; 339 (17): 1217-1227.
24. Becvarova I, Saker KE, Swecker WS Jr, Troy GC,. Peroxidative protection of parenteral admixture by D-alpha-tocopherol. Vet Therapeut. 2005; 6 (4): 280-290.
25. Sala-Vila A, Barbosa VM, Calder PC,. Olive oil in parenteral nutrition. Curr Opin Clin Nutr Metab Care. 2007; 10 (2): 165-174.
26. Vlaardingerbroek H, Veldhorst MA, Spronk S, van den Akker CH, van Goudoever JB,. Parenteral lipid administration to very-low-birth-weight infants-early introduction of lipids and use of new lipid emulsions: a systematic review and meta-analysis. Am J Clin Nutr. 2012; 96 (2): 255-268.
27. Krohn K, Koletzko B,. Parenteral lipid emulsions in paediatrics. Curr Opin Clin Nutr Metab Care. 2006; 9 (3): 319-323.
28. Ekema G, Falchetti D, Boroni G,. Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (omega-3 fatty acids). J Pediatr Surg. 2008; 43 (6): 1191-1195.
29. Puder M, Valim C, Meisel JA,. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg. 2009; 250 (3): 395-402.
30. Le HD, de Meijer VE, Robinson EM,. Parenteral fish-oil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-dependent children. Am J Clin Nutr. 2011; 94 (3): 749-758.
31. Cheung HM, Lam HS, Tam YH, Lee KH, Ng PC,. Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fish-oil-based lipid. Clin Nutr. 2009; 28 (2): 209-212.
32. Gura KM, Duggan CP, Collier SB,. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics. 2006; 118 (1): e197-e201.
33. Wanten GJ, Calder PC,. Immune modulation by parenteral lipid emulsions. Am J Clin Nutr. 2007; 85 (5): 1171-1184.
34. Grimm H, Mertes N, Goeters C,. Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients. Eur J Nutr. 2006; 45 (1): 55-60.
35. Food and Drug Administration. FDA approves Clinolipid for intravenous nutrition [press release]. 2013. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm370740.htm. Accessed June 3, 2014.
36. Higgins JPT, Green S,. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. 2011. http://www.cochrane-handbook.org
37. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P,. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010; 8 (5): 336-341.
38. Venick RS, Calkins K,. The impact of intravenous fish oil emulsions on pediatric intestinal failure-associated liver disease. Curr Opin Organ Transplant. 2011; 16 (3): 306-311.
39. Wallace BC SK, Brodley CE, Lau J, Trikalinos TA,. Deploying an interactive machine learning system in an evidence-based practice center: abstrackr. In: Proceedings of the 2nd ACM SIGHIT International Health Informatics Symposium. New York, NY: ACM; 2012: 819-824.
40. Wallace BC DI, Trikalinos TA, Lau J, Trow P, Schmid CH,. Closing the gap between methodoligists and end-users: R as a computational back-end. J Stat Softw. 2012; 49: 5.
41. Higgins JP, Altman DG, Gotzsche PC,. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. Br Med J. 2011; 343: d5928.
42. Wells GA, Shea B, O'Connell D,. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp
43. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7 (3): 177-188.
44. Yusuf S, Peto R, Lewis J, Collins R, Sleight P,. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985; 27 (5): 335-371.
45. Angsten G, Finkel Y, Lucas S, Kassa AM, Paulsson M, Lilja HE,. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with -6/9 lipid emulsions. JPEN J Parenter Enteral Nutr. 2012; 36 (5): 587-595.
46. Goulet O, Antebi H, Wolf C,. A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr. 2010; 34 (5): 485-495.
47. Larsen BM, Goonewardene LA, Joffe AR,. Pre-treatment with an intravenous lipid emulsion containing fish oil (eicosapentaenoic and docosahexaenoic acid) decreases inflammatory markers after open-heart surgery in infants: a randomized, controlled trial. Clin Nutr. 2012; 31 (3): 322-329.
48. Lilja HE, Finkel Y, Paulsson M, Lucas S,. Prevention and reversal of intestinal failure-associated liver disease in premature infants with short bowel syndrome using intravenous fish oil in combination with omega-6/9 lipid emulsions. J Pediatr Surg. 2011; 46 (7): 1361-1367.
49. Muhammed R, Bremner R, Protheroe S, Johnson T, Holden C, Murphy MS,. Resolution of parenteral nutrition-associated jaundice on changing from a soybean oil emulsion to a complex mixed-lipid emulsion. J Pediatr Gastroenterol Nutr. 2012; 54 (6): 797-802.
50. Rayyan M, Devlieger H, Jochum F, Allegaert K,. Short-term use of parenteral nutrition with a lipid emulsion containing a mixture of soybean oil, olive oil, medium-chain triglycerides, and fish oil: a randomized double-blind study in preterm infants. JPEN J Parenter Enteral Nutr. 2012; 36 (1)(suppl): 81S-94S.
51. Savini S, D'Ascenzo R, Biagetti C,. The effect of 5 intravenous lipid emulsions on plasma phytosterols in preterm infants receiving parenteral nutrition: a randomized clinical trial. Am J Clin Nutr. 2013; 98 (2): 312-318.
52. Skouroliakou M, Konstantinou D, Koutri K,. A double-blind, randomized clinical trial of the effect of omega-3 fatty acids on the oxidative stress of preterm neonates fed through parenteral nutrition. Eur J Clin Nutr. 2010; 64 (9): 940-947.
53. Tomsits E, Pataki M, Tolgyesi A, Fekete G, Rischak K, Szollar L,. Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil: a randomised, double-blind clinical trial in premature infants requiring parenteral nutrition. J Pediatr Gastroenterol Nutr. 2010; 51 (4): 514-521.